title: Iatrogenic phospholipidosis mimicking Fabry disease.
authors.forename: Erika R
authors.initials: ER
authors.lastname: Bracamonte
authors.forename: Jolanta
authors.initials: J
authors.lastname: Kowalewska
authors.forename: Jonathan
authors.initials: J
authors.lastname: Starr
authors.forename: Jeremy
authors.initials: J
authors.lastname: Gitomer
authors.forename: Charles E
authors.initials: CE
authors.lastname: Alpers
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects*; D004252:DNA Mutational Analysis; D003937:Diagnosis, Differential; D004847:Epithelial Cells / Q000473:pathology; D000795:Fabry Disease / Q000175:diagnosis* / Q000473:pathology; D005260:Female; D006801:Humans; D006886:Hydroxychloroquine / Q000009:adverse effects*; D007668:Kidney / Q000473:pathology; D007674:Kidney Diseases / Q000139:chemically induced*; D007678:Kidney Glomerulus / Q000473:pathology; D008064:Lipidoses / Q000139:chemically induced*; D008856:Microscopy, Fluorescence; D008875:Middle Aged; D000519:alpha-Galactosidase / Q000235:genetics / Q000378:metabolism
chemical_list: D018501:Antirheumatic Agents; D006886:Hydroxychloroquine; D000519:alpha-Galactosidase